Cargando…
Reprogramming for cardiac regeneration
Treatment of cardiovascular diseases remains challenging considering the limited regeneration capacity of the heart muscle. Developments of reprogramming strategies to create in vitro and in vivo cardiomyocytes have been the focus point of a considerable amount of research in the past decades. The c...
Autores principales: | Raynaud, Christophe Michel, Ahmad, Faizzan Syed, Allouba, Mona, Abou-Saleh, Haissam, Lui, Kathy O., Yacoub, Magdi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bloomsbury Qatar Foundation Journals
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4352683/ https://www.ncbi.nlm.nih.gov/pubmed/25763379 http://dx.doi.org/10.5339/gcsp.2014.44 |
Ejemplares similares
-
Alginate for cardiac regeneration: From seaweed to clinical trials
por: Liberski, Albert, et al.
Publicado: (2016) -
Direct Cardiac Reprogramming: Advances in Cardiac Regeneration
por: Chen, Olivia, et al.
Publicado: (2015) -
Clinical trials of bone marrow derived cells for ischemic heart failure. Time to move on? TIME, SWISS-AMI, CELLWAVE, POSEIDON and C-CURE
por: Raynaud, Christophe M., et al.
Publicado: (2013) -
Direct Reprogramming—The Future of Cardiac Regeneration?
por: Doppler, Stefanie A., et al.
Publicado: (2015) -
NaNog: A pluripotency homeobox (master) molecule
por: Allouba, Mona H., et al.
Publicado: (2015)